Veda Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
- Paid Up Capital ₹ 2.60 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 2.75 Cr
- Revenue Growth -54.16%
- Profit Growth -29.08%
- Ebitda -54.16%
- Net Worth 12.72%
- Total Assets 8.28%
About Veda Lifesciences
Veda Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2008 and has a history of 16 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹2.75 Cr.
Kolanuvada Raju and Padmanabha Chekuri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74900TG2008PTC061837
- Company No.
061837
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2008
- Date of AGM
29 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Veda Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kolanuvada Raju  | Director | 17-Nov-2008 | Current |
| Padmanabha Chekuri | Director | 22-Nov-2008 | Current |
Financial Performance of Veda Lifesciences.
Veda Lifesciences Private Limited, for the financial year ended 2014, experienced significant reduction in revenue, with a 54.16% decrease. The company also saw a substantial fall in profitability, with a 29.08% decrease in profit. The company's net worth Soared by an impressive increase of 12.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Veda Lifesciences?
In 2015, Veda Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹27.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Syndicate Bank : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2017 | Others | ₹2.00 Cr | Open |
| 13 Aug 2012 | Syndicate Bank | ₹7.50 M | Open |
How Many Employees Work at Veda Lifesciences?
Unlock and access historical data on people associated with Veda Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veda Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veda Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
